Fortaz
NDC Package 52565-109-06
Package Information
Fortaz is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases:1.Lower Respiratory Tract Infections, including pneumonia, caused by Pseudomonas aeruginosa and other Pseudomonas spp.; Haemophilus influenzae, including ampicillin-resistant strains; Klebsiella spp.; Enterobacter spp.; Proteus mirabilis; Escherichia coli; Serratia spp.; Citrobacter spp.; Streptococcus pneumoniae; and Staphylococcus aureus (methicillin-susceptible strains).2.Skin and Skin-Structure Infections caused by Pseudomonas aeruginosa; Klebsiella spp.; Escherichia coli; Proteus spp., including Proteus mirabilis and indole-positive Proteus; Enterobacter spp.; Serratia spp.; Staphylococcus aureus (methicillin-susceptible strains); and Streptococcus pyogenes (group A beta-hemolytic streptococci).3.Urinary Tract Infections, both complicated and uncomplicated, caused by Pseudomonas aeruginosa; Enterobacter spp.; Proteus spp., including Proteus mirabilis and indole-positive Proteus; Klebsiella spp.; and Escherichia coli.4.Bacterial Septicemia caused by Pseudomonas aeruginosa, Klebsiella spp., Haemophilus influenzae, Escherichia coli, Serratia spp., Streptococcus pneumoniae, and Staphylococcus aureus (methicillin-susceptible strains).5.Bone and Joint Infections caused by Pseudomonas aeruginosa, Klebsiella spp., Enterobacter spp., and Staphylococcus aureus (methicillin-susceptible strains).6.Gynecologic Infections, including endometritis, pelvic cellulitis, and other infections of the female genital tract caused by Escherichia coli.7.Intra-abdominal Infections, including peritonitis caused by Escherichia coli, Klebsiella spp., and Staphylococcus aureus (methicillin-susceptible strains) and polymicrobial infections caused by aerobic and anaerobic organisms and Bacteroides spp. Marketed by Teligent Pharma, Inc., this product is identified by NDC 52565-109 and is authorized under FDA application NDA050578.
Identification & Billing
- RxCUI: 206422 - Fortaz 200 MG/ML Injectable Solution
- RxCUI: 206422 - ceftazidime 200 MG/ML Injectable Solution [Fortaz]
- RxCUI: 206422 - Fortaz 6 GM per 30 ML Injectable Solution
- RxCUI: 242800 - cefTAZidime 200 MG/ML Injectable Solution
- RxCUI: 242800 - ceftazidime 200 MG/ML Injectable Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 52565 - Teligent Pharma, Inc.
- 52565-109 - Fortaz
- 52565-109-06 - 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY / 127 mL in 1 VIAL, PHARMACY BULK PACKAGE
- 52565-109 - Fortaz
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52565-109-06 identifies a specific commercial package of 6 vial, pharmacy bulk package in 1 tray / 127 ml in 1 vial, pharmacy bulk package of Fortaz, labeled by Teligent Pharma, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Teligent Pharma, Inc. on June 20, 2017. The current certification is valid through December 31, 2020.
How is this Teligent Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52565010906. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.